Stay updated with breaking news from Garyl crocker. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) Short Interest Update themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
StockNews.com began coverage on shares of Merrimack Pharmaceuticals (NASDAQ:MACK – Free Report) in a research note issued to investors on Thursday. The firm issued a sell rating on the biopharmaceutical company’s stock. Merrimack Pharmaceuticals Trading Up 1.5 % NASDAQ MACK traded up $0.18 on Thursday, hitting $12.19. 26,084 shares of the company’s stock traded hands, […] ....
Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK – Get Free Report) insider Gary L. Crocker purchased 2,000 shares of the business’s stock in a transaction on Thursday, August 10th. The stock was bought at an average cost of $12.52 per share, with a total value of $25,040.00. Following the purchase, the insider now owns 133,105 shares in the […] ....
Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK – Get Rating)’s stock price passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $5.46 and traded as high as $5.89. Merrimack Pharmaceuticals shares last traded at $5.68, with a volume of 7,552 shares. Separately, StockNews.com started coverage on Merrimack Pharmaceuticals […] ....
StockNews.com assumed coverage on shares of Merrimack Pharmaceuticals (NASDAQ:MACK – Get Rating) in a note issued to investors on Monday. The firm set a “sell” rating on the biopharmaceutical company’s stock. Shares of MACK opened at $4.95 on Monday. The firm’s 50-day moving average price is $5.71 and its 200-day moving average price is $5.30. […] ....